Ga-68 PSMA-HBED-CC PET

DRUG3 trials

Sponsors

Michael Graham PhD, MD

Conditions

Prostate CancerProstatic Cancer MetastaticProstatic Cancer RecurrentProstatic NeoplasmProstatic Neoplasm of Uncertain BehaviorProstatic NeoplasmsProstatic Neoplasms, Castration-Resistant

Phase 2

68Ga PSMA in Preprostatectomy Patients

CompletedNCT03388346

Michael Graham PhD, MDProstate Cancer, Prostatic Neoplasm, Prostatic Neoplasm of Uncertain Behavior +1

Start: 2018-02-16End: 2021-07-22Updated: 2024-02-15

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

CompletedNCT03389451

Michael Graham PhD, MDProstate Cancer, Prostatic Cancer Metastatic, Prostatic Cancer Recurrent +2

Start: 2018-02-16End: 2019-07-23Updated: 2024-07-12

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

CompletedNCT03822845

Michael Graham PhD, MDProstatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Start: 2019-03-01End: 2021-03-30Updated: 2025-04-17